Actionnariat et activité des initiés pour Cerus Corporation (CERS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.53 |
| Capitalisation | $510M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $22.6M | $13.7M | $28.9M | $35.0M | $36.6M | $48.8M | $35.6M | $11.6M | $20.3M | $20.0M |
| Placements à Court Terme | $49.1M | $47.0M | $88.7M | $50.7M | $97.0M | $80.6M | $66.6M | $54.2M | $60.2M | $62.9M |
| Créances | $6.9M | $12.4M | $8.8M | $16.9M | $21.2M | $25.1M | $34.4M | $35.5M | $29.8M | $30.4M |
| Stocks | $12.5M | $14.5M | $13.5M | $19.5M | $23.3M | $26.8M | $29.0M | $39.9M | $38.1M | $56.1M |
| Actifs Courants | $94.1M | $89.9M | $146.9M | $128.1M | $183.4M | $187.1M | $170.1M | $144.4M | $152.0M | $174.4M |
| Immobilisations Corporelles | $3.0M | $2.1M | $8.1M | $29.0M | $27.0M | $25.2M | $23.5M | $19.4M | $15.5M | $19.3M |
| Goodwill | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
| Actifs Incorporels | $738000 | $536000 | $334000 | $132000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $103.5M | $98.2M | $163.5M | $165.5M | $221.4M | $237.5M | $218.1M | $197.7M | $200.9M | $221.9M |
| Dettes Fournisseurs | $8.6M | $11.0M | $18.6M | $22.2M | $24.2M | $35.6M | $33.0M | $23.8M | $21.7M | $28.0M |
| Dette à Court Terme | $6.9M | 0 | $7.9M | $5.0M | $8.5M | $14.7M | $56.2M | $20.0M | $19.3M | $43.3M |
| Passifs Courants | $26.9M | $23.1M | $52.7M | $50.3M | $60.0M | $78.6M | $117.1M | $67.5M | $63.6M | $100.8M |
| Dette à Long Terme | $12.4M | $29.8M | $22.0M | $39.4M | $39.6M | $54.7M | $13.6M | $59.8M | $64.9M | $40.5M |
| Passifs Totaux | $45.7M | $59.3M | $78.9M | $108.5M | $117.6M | $151.9M | $149.5M | $144.3M | $144.0M | $156.9M |
| Réserves | -$660.7M | -$721.3M | -$778.9M | -$850.1M | -$910.0M | -$964.3M | -$1.01B | -$1.04B | -$1.07B | -$1.08B |
| Capitaux Propres | $57.8M | $38.9M | $84.5M | $57.1M | $103.8M | $84.6M | $67.6M | $52.6M | $56.1M | $64.2M |
| Dette Totale | $19.4M | $29.8M | $29.9M | $64.5M | $66.9M | $87.6M | $87.2M | $96.0M | $98.1M | $96.9M |
| Dette Nette | -$52.3M | -$30.9M | -$87.7M | -$21.3M | -$66.7M | -$41.8M | -$14.9M | $30.1M | $17.6M | $14.1M |
| Fonds de Roulement | $67.2M | $66.8M | $94.2M | $77.8M | $123.5M | $108.5M | $53.1M | $76.9M | $88.4M | $73.6M |
Santé financière
| Dette / Capitaux propres | 1.10 |
| Ratio de liquidité | 1.83 |
Rentabilité
| Rentabilité des capitaux propres | -10.31% |
| Rentabilité du capital investi | -1.06% |
| Rentabilité des actifs | -3.31% |
| Marge brute | 52.05% |
| Marge opérationnelle | -0.73% |
| Marge nette | -3.06% |
Entreprises liées: CVRX · MASS · NPCE · QTRX · RXST · SENS · SGHT
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de CERS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions